🇺🇸 FDA
Pipeline program

Triptorelin for Injection

GenSci 067 CT

Phase 3 small_molecule active

Quick answer

Triptorelin for Injection for Ovarian Hyperstimulation Syndrome is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Ovarian Hyperstimulation Syndrome
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials